2,615 results on '"Caraglia A"'
Search Results
2. Tissue expression of miR-449a as risk factor for occult neck metastasis in patients with cT3-T4 N0 laryngeal cancer. A pilot study
- Author
-
Ricciardiello, Filippo, Falco, Michela, Scarpa, Alfonso, Motta, Giovanni, Viola, Pasquale, Bocchetti, Marco, Caraglia, Michele, Alfieri, Nello, Oliva, Flavia, Tammaro, Chiara, Tortoriello, Giuseppe, Radici, Marco, Camaioni, Angelo, Misso, Gabriella, and De Luca, Pietro
- Published
- 2024
- Full Text
- View/download PDF
3. Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation
- Author
-
Grisolia, Piera, Tufano, Rossella, Iannarone, Clara, De Falco, Antonio, Carlino, Francesca, Graziano, Cinzia, Addeo, Raffaele, Scrima, Marianna, Caraglia, Francesco, Ceccarelli, Anna, Nuzzo, Pier Vitale, Cossu, Alessia Maria, Forte, Stefano, Giuffrida, Raffaella, Orditura, Michele, Caraglia, Michele, and Ceccarelli, Michele
- Published
- 2024
- Full Text
- View/download PDF
4. Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer
- Author
-
Bocchetti, Marco, Luce, Amalia, Iannarone, Clara, Pasquale, Lucia Stefania, Falco, Michela, Tammaro, Chiara, Abate, Marianna, Ferraro, Maria Grazia, Addeo, Raffaele, Ricciardiello, Filippo, Motta, Giovanni, De Stefano, Luca, Caraglia, Francesco, Ceccarelli, Anna, Zappavigna, Silvia, Scrima, Marianna, Cossu, Alessia Maria, Caraglia, Michele, and Misso, Gabriella
- Published
- 2024
- Full Text
- View/download PDF
5. Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment
- Author
-
Ottaiano, Alessandro, Santorsola, Mariachiara, Ianniello, Monica, Ceccarelli, Anna, Casillo, Marika, Sabbatino, Francesco, Petrillo, Nadia, Cascella, Marco, Caraglia, Francesco, Picone, Carmine, Perri, Francesco, Sirica, Roberto, Zappavigna, Silvia, Nasti, Guglielmo, Savarese, Giovanni, and Caraglia, Michele
- Published
- 2024
- Full Text
- View/download PDF
6. Introducing comprehensive sexuality education in Italian schools: from the co-construction to the evaluation of a pilot intervention
- Author
-
Alice Chinelli, Marco Ubbiali, Gianluca Paparatto, Eleonora Torri, Angelo Musco, Rosario Galipò, Paolo Meli, Sabrina Bellini, Nicola Catucci, Ludovica Colaprico, Antonella Camposeragna, Massimo Farinella, Laura Rancilio, Nicoletta Landi, Piero Stettini, Maria Cristina Salfa, Andrea Cellini, Barbara Suligoi, Anna Teresa Palamara, Luigina Mortari, Anna Caraglia, Domenico Martinelli, and Lara Tavoschi
- Subjects
Italy ,Sexual health ,School-based education ,Comprehensive sexuality education ,Evaluation ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Introduction School-based comprehensive sexuality education (CSE) is a powerful tool that provides young people with information on all aspects of sexuality and is aimed at protecting their sexual and reproductive health and well-being throughout their lives. Currently, CSE is not integrated within the schools’ curriculum in Italy. This study describes the co-construction, implementation, and evaluation of a CSE project piloted among students attending lower secondary schools, in four regions of Italy. Evidence-based evaluation will be helpful in promote the inclusion of CSE programs in the Italian schools’ curriculum. Methods The pilot scheme was co-constructed by a multidisciplinary curriculum development group through a Delphi process, including educators who conducted the activities. The evaluation followed three directions: the program (based on a literature review of CSE principles and recommended characteristics), implementation (assessing the execution of the program through the analysis of the reflection tools used by the educators), and short-term outcomes (assessing critical thinking and conscious behavioural choices through pre-post and satisfaction surveys). Results The main goal, learning modules and content were defined and structured in five interventions with the students, and two with families and teachers. A total of 638 students were involved in the activity, across 11 schools. Data analysis of pre/post surveys reported a significant increase in knowledge in 12 of the 15 items investigated (p
- Published
- 2024
- Full Text
- View/download PDF
7. Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer
- Author
-
Marco Bocchetti, Amalia Luce, Clara Iannarone, Lucia Stefania Pasquale, Michela Falco, Chiara Tammaro, Marianna Abate, Maria Grazia Ferraro, Raffaele Addeo, Filippo Ricciardiello, Giovanni Motta, Luca De Stefano, Francesco Caraglia, Anna Ceccarelli, Silvia Zappavigna, Marianna Scrima, Alessia Maria Cossu, Michele Caraglia, and Gabriella Misso
- Subjects
Exosomes ,Laryngeal cancer ,Membrane epitopes ,Early diagnosis ,Liquid biopsy ,Medicine - Abstract
Abstract Background Exosomes are nanosized vesicles released from all cells into surrounding biofluids, including cancer cells, and represent a very promising direction in terms of minimally invasive approaches to early disease detection. They carry tumor-specific biological contents such as DNA, RNA, proteins, lipids, and sugars, as well as surface molecules that are able to pinpoint the cellular source. By the above criteria, exosomes may be stratified according to the presence of tissue and disease-specific signatures and, due to their stability in such biofluids as plasma and serum, they represent an indispensable source of vital clinical insights from liquid biopsies, even at the earliest stages of cancer. Therefore, our work aimed to isolate and characterize LCa patients’ derived exosomes from serum by Flow Cytometry in order to define a specific epitope signature exploitable for early diagnosis. Methods Circulating exosomes were collected from serum collected from 30 LCa patients and 20 healthy volunteers by the use of antibody affinity method exploiting CD63 specific surface marker. Membrane epitopes were then characterized by Flow cytometry multiplex analysis and compared between LCa Patients and Healthy donors. Clinical data were also matched to obtain statistical correlation. Results A distinct overexpression of CD1c, CD2, CD3, CD4, CD11c, CD14, CD20, CD44, CD56, CD105, CD146, and CD209 was identified in LCa patients compared to healthy controls, correlating positively with tumor presence. Conversely, CD24, CD31, and CD40, though not overexpressed in tumor samples, showed a significant correlation with nodal involvement in LCa patients (p < 0.01). Conclusion This approach could allow us to set up a cost-effective and less invasive liquid biopsy protocol from a simple blood collection in order to early diagnose LCa and improve patients’ outcomes and quality of life. Graphical Abstract
- Published
- 2024
- Full Text
- View/download PDF
8. Introducing comprehensive sexuality education in Italian schools: from the co-construction to the evaluation of a pilot intervention
- Author
-
Chinelli, Alice, Ubbiali, Marco, Paparatto, Gianluca, Torri, Eleonora, Musco, Angelo, Galipò, Rosario, Meli, Paolo, Bellini, Sabrina, Catucci, Nicola, Colaprico, Ludovica, Camposeragna, Antonella, Farinella, Massimo, Rancilio, Laura, Landi, Nicoletta, Stettini, Piero, Salfa, Maria Cristina, Cellini, Andrea, Suligoi, Barbara, Palamara, Anna Teresa, Mortari, Luigina, Caraglia, Anna, Martinelli, Domenico, and Tavoschi, Lara
- Published
- 2024
- Full Text
- View/download PDF
9. Development of a prediction model of conversion to Alzheimer’s disease in people with mild cognitive impairment: the statistical analysis plan of the INTERCEPTOR project
- Author
-
Lombardo, Flavia L., Lorenzini, Patrizia, Mayer, Flavia, Massari, Marco, Piscopo, Paola, Bacigalupo, Ilaria, Ancidoni, Antonio, Sciancalepore, Francesco, Locuratolo, Nicoletta, Remoli, Giulia, Salemme, Simone, Cappa, Stefano, Perani, Daniela, Spadin, Patrizia, Tagliavini, Fabrizio, Redolfi, Alberto, Cotelli, Maria, Marra, Camillo, Caraglia, Naike, Vecchio, Fabrizio, Miraglia, Francesca, Rossini, Paolo Maria, and Vanacore, Nicola
- Published
- 2024
- Full Text
- View/download PDF
10. Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma
- Author
-
Falco, Michela, Tammaro, Chiara, Cossu, Alessia Maria, Takeuchi, Takashi, Tufano, Rossella, Ceccarelli, Michele, Scafuro, Giuseppe, Zappavigna, Silvia, Grimaldi, Anna, Scrima, Marianna, Ottaiano, Alessandro, Savarese, Giovanni, Fico, Antonio, Mesolella, Massimo, Fasano, Morena, Motta, Giovanni, Massimilla, Eva Aurora, Addeo, Raffaele, Ricciardiello, Filippo, Caraglia, Michele, and Misso, Gabriella
- Published
- 2024
- Full Text
- View/download PDF
11. Immune cell infiltration and inflammatory landscape in primary brain tumours
- Author
-
Luce, Amalia, Abate, Marianna, Scognamiglio, Giosuè, Montella, Marco, Iervolino, Domenico, Campione, Severo, Di Mauro, Annabella, Sepe, Orlando, Gigantino, Vincenzo, Tathode, Madhura S., Ferrara, Gerardo, Monaco, Roberto, De Dominicis, Gianfranco, Misso, Gabriella, Gentile, Vittorio, Franco, Renato, Zappavigna, Silvia, and Caraglia, Michele
- Published
- 2024
- Full Text
- View/download PDF
12. The decline of the 2022 Italian mpox epidemic: Role of behavior changes and control strategies
- Author
-
Guzzetta, Giorgio, Marziano, Valentina, Mammone, Alessia, Siddu, Andrea, Ferraro, Federica, Caraglia, Anna, Maraglino, Francesco, Rezza, Giovanni, Vespignani, Alessandro, Longini, Ira, Ajelli, Marco, and Merler, Stefano
- Published
- 2024
- Full Text
- View/download PDF
13. A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario
- Author
-
Di Lorenzo, Giuseppe, Michele, Aieta, Silvana, Leo, Bilancia, Domenico, Di Trolio, Rossella, Iuliucci, Michela Rosaria, Ingenito, Concetta, Rubino, Roberta, Piscosquito, Arianna, Caraglia, Michele, Donnarumma, Marianna, Costabile, Ferdinando, Conca, Raffaele, Pisino, Marco, Vaia, Angelo, Scafuri, Luca, Verde, Antonio, and Buonerba, Carlo
- Published
- 2024
- Full Text
- View/download PDF
14. Development of a prediction model of conversion to Alzheimer’s disease in people with mild cognitive impairment: the statistical analysis plan of the INTERCEPTOR project
- Author
-
Flavia L. Lombardo, Patrizia Lorenzini, Flavia Mayer, Marco Massari, Paola Piscopo, Ilaria Bacigalupo, Antonio Ancidoni, Francesco Sciancalepore, Nicoletta Locuratolo, Giulia Remoli, Simone Salemme, Stefano Cappa, Daniela Perani, Patrizia Spadin, Fabrizio Tagliavini, Alberto Redolfi, Maria Cotelli, Camillo Marra, Naike Caraglia, Fabrizio Vecchio, Francesca Miraglia, Paolo Maria Rossini, Nicola Vanacore, and the INTERCEPTOR Network
- Subjects
Statistical analysis plan ,Longitudinal study ,Mild cognitive impairment ,Dementia ,Alzheimer’s disease ,Biomarker ,Medicine (General) ,R5-920 - Abstract
Abstract Background In recent years, significant efforts have been directed towards the research and development of disease-modifying therapies for dementia. These drugs focus on prodromal (mild cognitive impairment, MCI) and/or early stages of Alzheimer’s disease (AD). Literature evidence indicates that a considerable proportion of individuals with MCI do not progress to dementia. Identifying individuals at higher risk of developing dementia is essential for appropriate management, including the prescription of new disease-modifying therapies expected to become available in clinical practice in the near future. Methods The ongoing INTERCEPTOR study is a multicenter, longitudinal, interventional, non-therapeutic cohort study designed to enroll 500 individuals with MCI aged 50–85 years. The primary aim is to identify a biomarker or a set of biomarkers able to accurately predict the conversion from MCI to AD dementia within 3 years of follow-up. The biomarkers investigated in this study are neuropsychological tests (mini-mental state examination (MMSE) and delayed free recall), brain glucose metabolism ([18F]FDG-PET), MRI volumetry of the hippocampus, EEG brain connectivity, cerebrospinal fluid (CSF) markers (p-tau, t-tau, Aβ1-42, Aβ1-42/1–40 ratio, Aβ1-42/p-Tau ratio) and APOE genotype. The baseline visit includes a full cognitive and neuropsychological evaluation, as well as the collection of clinical and socio-demographic information. Prognostic models will be developed using Cox regression, incorporating individual characteristics and biomarkers through stepwise selection. Model performance will be evaluated in terms of discrimination and calibration and subjected to internal validation using the bootstrapping procedure. The final model will be visually represented as a nomogram. Discussion This paper contains a detailed description of the statistical analysis plan to ensure the reproducibility and transparency of the analysis. The prognostic model developed in this study aims to identify the population with MCI at higher risk of developing AD dementia, potentially eligible for drug prescriptions. The nomogram could provide a valuable tool for clinicians for risk stratification and early treatment decisions. Trial registration ClinicalTrials.gov NCT03834402. Registered on February 8, 2019
- Published
- 2024
- Full Text
- View/download PDF
15. Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma
- Author
-
Michela Falco, Chiara Tammaro, Alessia Maria Cossu, Takashi Takeuchi, Rossella Tufano, Michele Ceccarelli, Giuseppe Scafuro, Silvia Zappavigna, Anna Grimaldi, Marianna Scrima, Alessandro Ottaiano, Giovanni Savarese, Antonio Fico, Massimo Mesolella, Morena Fasano, Giovanni Motta, Eva Aurora Massimilla, Raffaele Addeo, Filippo Ricciardiello, Michele Caraglia, and Gabriella Misso
- Subjects
Laryngeal Squamous Cell Cancer ,miRNA ,miRNA signature ,ROC curve ,miR-532 ,miR-93 ,Medicine - Abstract
Abstract Background The growing understanding of cancer biology and the establishment of new treatment modalities has not yielded the expected results in terms of survival for Laryngeal Squamous Cell Cancer (LSCC). Early diagnosis, as well as prompt identification of patients with high risk of relapse would ensure greater chance of therapeutic success. However, this goal remains a challenge due to the absence of specific biomarkers for this neoplasm. Methods Serum samples from 45 LSCC patients and 23 healthy donors were collected for miRNA expression profiling by TaqMan Array analysis. Additional 20 patients and 42 healthy volunteers were included for the validation set, reaching an equal number of clinical samples for each group. The potential diagnostic ability of the such identified three-miRNA signature was confirmed by ROC analysis. Moreover, each miRNA was analyzed for the possible correlation with HNSCC patients’ survival and TNM status by online databases Kaplan–Meier (KM) plotter and OncomiR. In silico analysis of common candidate targets and their network relevance to predict shared biological functions was finally performed by PANTHER and GeneMANIA software. Results We characterized serum miRNA profile of LSCC patients identifying a novel molecular signature, including miR-223, miR-93 and miR-532, as circulating marker endowed with high selectivity and specificity. The oncogenic effect and the prognostic significance of each miRNA was investigated by bioinformatic analysis, denoting significant correlation with OS. To analyse the molecular basis underlying the pro-tumorigenic role of the signature, we focused on the simultaneously regulated gene targets—IL6ST, GTDC1, MAP1B, CPEB3, PRKACB, NFIB, PURB, ATP2B1, ZNF148, PSD3, TBC1D15, PURA, KLF12—found by prediction tools and deepened for their functional role by pathway enrichment analysis. The results showed the involvement of 7 different biological processes, among which inflammation, proliferation, migration, apoptosis and angiogenesis. Conclusions In conclusion, we have identified a possible miRNA signature for early LSCC diagnosis and we assumed that miR-93, miR-223 and miR-532 could orchestrate the regulation of multiple cancer-related processes. These findings encourage the possibility to deepen the molecular mechanisms underlying their oncogenic role, for the desirable development of novel therapeutic opportunities based on the use of short single-stranded oligonucleotides acting as non-coding RNA antagonists in cancer.
- Published
- 2024
- Full Text
- View/download PDF
16. Immune cell infiltration and inflammatory landscape in primary brain tumours
- Author
-
Amalia Luce, Marianna Abate, Giosuè Scognamiglio, Marco Montella, Domenico Iervolino, Severo Campione, Annabella Di Mauro, Orlando Sepe, Vincenzo Gigantino, Madhura S. Tathode, Gerardo Ferrara, Roberto Monaco, Gianfranco De Dominicis, Gabriella Misso, Vittorio Gentile, Renato Franco, Silvia Zappavigna, and Michele Caraglia
- Subjects
Meningioma ,Glioblastoma ,Astrocytoma ,Inflammation ,5-Lypoxygenase ,Immune cell infiltration ,Medicine - Abstract
Abstract Background Primary malignant brain tumours are more than one-third of all brain tumours and despite the molecular investigation to identify cancer driver mutations, the current therapeutic options available are challenging due to high intratumour heterogeneity. In addition, an immunosuppressive and inflammatory tumour microenvironment strengthens cancer progression. Therefore, we defined an immune and inflammatory profiling of meningioma and glial tumours to elucidate the role of the immune infiltration in these cancer types. Methods Using tissue microarrays of 158 brain tumour samples, we assessed CD3, CD4, CD8, CD20, CD138, Granzyme B (GzmB), 5-Lipoxygenase (5-LOX), Programmed Death-Ligand 1 (PD-L1), O-6-Methylguanine-DNA Methyltransferase (MGMT) and Transglutaminase 2 (TG2) expression by immunohistochemistry (IHC). IHC results were correlated using a Spearman correlation matrix. Transcript expression, correlation, and overall survival (OS) analyses were evaluated using public datasets available on GEPIA2 in Glioblastoma (GBM) and Lower Grade Glioma (LGG) cohorts. Results Seven out of ten markers showed a significantly different IHC expression in at least one of the evaluated cohorts whereas CD3, CD4 and 5-LOX were differentially expressed between GBMs and astrocytomas. Correlation matrix analysis revealed that 5-LOX and GzmB expression were associated in both meningiomas and GBMs, whereas 5-LOX expression was significantly and positively correlated to TG2 in both meningioma and astrocytoma cohorts. These findings were confirmed with the correlation analysis of TCGA-GBM and LGG datasets. Profiling of mRNA levels indicated a significant increase in CD3 (CD3D, CD3E), and CD138 (SDC1) expression in GBM compared to control tissues. CD4 and 5-LOX (ALOX5) mRNA levels were significantly more expressed in tumour samples than in normal tissues in both GBM and LGG. In GBM cohort, GzmB (GZMB), SDC1 and MGMT gene expression predicted a poor overall survival (OS). Moreover, in LGG cohort, an increased expression of CD3 (CD3D, CD3E, CD3G), CD8 (CD8A), GZMB, CD20 (MS4A1), SDC1, PD-L1, ALOX5, and TG2 (TGM2) genes was associated with worse OS. Conclusions Our data have revealed that there is a positive and significant correlation between the expression of 5-LOX and GzmB, both at RNA and protein level. Further evaluation is needed to understand the interplay of 5-LOX and immune infiltration in glioma progression.
- Published
- 2024
- Full Text
- View/download PDF
17. Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment
- Author
-
Alessandro Ottaiano, Mariachiara Santorsola, Monica Ianniello, Anna Ceccarelli, Marika Casillo, Francesco Sabbatino, Nadia Petrillo, Marco Cascella, Francesco Caraglia, Carmine Picone, Francesco Perri, Roberto Sirica, Silvia Zappavigna, Guglielmo Nasti, Giovanni Savarese, and Michele Caraglia
- Subjects
TAS-102 ,FGFR4 ,Colorectal cancer ,NGS ,Medicine - Abstract
Abstract Background TAS-102 (Lonsurf®) is an oral fluoropyrimidine consisting of a combination of trifluridine (a thymidine analog) and tipiracil (a thymidine phosphorylation inhibitor). The drug is effective in metastatic colorectal cancer (mCRC) patients refractory to fluorouracil, irinotecan and oxaliplatin. This study is a real-world analysis, investigating the interplay of genotype/phenotype in relation to TAS-102 sensitivity. Methods Forty-seven consecutive mCRC patients were treated with TAS-102 at the National Cancer Institute of Naples from March 2019 to March 2021, at a dosage of 35 mg/m2, twice a day, in cycles of 28 days (from day 1 to 5 and from day 8 to 12). Clinical-pathological parameters were described. Activity was evaluated with RECIST criteria (v1.1) and toxicity with NCI-CTC (v5.0). Survival was depicted through the Kaplan-Meyer curves. Genetic features of patients were evaluated with Next Generation Sequencing (NGS) through the Illumina NovaSeq 6000 platform and TruSigt™Oncology 500 kit. Results Median age of patients was 65 years (range: 46–77). Forty-one patients had 2 or more metastatic sites and 38 patients underwent to more than 2 previous lines of therapies. ECOG (Eastern Cooperative Oncology Group) Performance Status (PS) was 2 in 19 patients. The median number of TAS-102 cycles was 4 (range: 2–12). The most frequent toxic event was neutropenia (G3/G4 in 16 patients). There were no severe (> 3) non-haematological toxicities or treatment-related deaths. Twenty-six patients experienced progressive disease (PD), 21 stable disease (SD). Three patients with long-lasting disease control (DC: complete, partial responses or stable disease) shared an FGFR4 (p.Gly388Arg) mutation. Patients experiencing DC had more frequently a low tumour growth rate (P = 0.0306) and an FGFR4 p.G388R variant (P
- Published
- 2024
- Full Text
- View/download PDF
18. The decline of the 2022 Italian mpox epidemic: Role of behavior changes and control strategies
- Author
-
Giorgio Guzzetta, Valentina Marziano, Alessia Mammone, Andrea Siddu, Federica Ferraro, Anna Caraglia, Francesco Maraglino, Giovanni Rezza, Alessandro Vespignani, Ira Longini, Marco Ajelli, and Stefano Merler
- Subjects
Science - Abstract
Abstract In 2022, a global outbreak of mpox occurred, predominantly impacting men who have sex with men (MSM). The rapid decline of this epidemic is yet to be fully understood. We investigated the Italian outbreak by means of an individual-based mathematical model calibrated to surveillance data. The model accounts for transmission within the MSM sexual contact network, in recreational and sex clubs attended by MSM, and in households. We indicate a strong spontaneous reduction in sexual transmission (61-87%) in affected MSM communities as the possible driving factor for the rapid decline in cases. The MSM sexual contact network was the main responsible for transmission (about 80%), with clubs and households contributing residually. Contact tracing prevented about half of the potential cases, and a higher success rate in tracing contacts could significantly amplify its effectiveness. Notably, immunizing the 23% of MSM with the highest sexual activity (10 or more partners per year) could completely prevent new mpox resurgences. This research underscores the importance of augmenting contact tracing, targeted immunization campaigns of high-risk groups, and fostering reactive behavioral changes as key strategies to manage and prevent the spread of emerging sexually transmitted pathogens like mpox within the MSM community.
- Published
- 2024
- Full Text
- View/download PDF
19. Early estimates on monkeypox incubation period, generation time and reproduction number in Italy, May-June 2022
- Author
-
Guzzetta, Giorgio, Mammone, Alessia, Ferraro, Federica, Caraglia, Anna, Rapiti, Alessia, Marziano, Valentina, Poletti, Piero, Cereda, Danilo, Vairo, Francesco, Mattei, Giovanna, Maraglino, Francesco, Rezza, Giovanni, and Merler, Stefano
- Subjects
Quantitative Biology - Populations and Evolution - Abstract
We analyzed the first 255 PCR-confirmed cases of monkeypox occurred in Italy in 2022. Preliminary estimates indicate: mean incubation period of 9.1 days (95%CI of the mean: 6.5-10.9); mean generation time of 12.5 days (95%CI of the mean: 7.5-17.3); reproduction number in the MSM community of 2.43 (95%CI: 1.82-3.26)., Comment: 3 pages, 1 figure, 1 table, supplementary material
- Published
- 2022
20. Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma
- Author
-
Vincenzo De Falco, Stefania Napolitano, Renato Franco, Federica Zito Marino, Luigi Formisano, Daniela Esposito, Gabriella Suarato, Rossella Napolitano, Alfonso Esposito, Francesco Caraglia, Maria Cristina Giugliano, Eleonora Cioli, Vincenzo Famiglietti, Roberto Bianco, Giuseppe Argenziano, Andrea Ronchi, Davide Ciardiello, Valerio Nardone, Emma D’Ippolito, Sara Del Tufo, Fortunato Ciardiello, and Teresa Troiani
- Subjects
Cemiplimab ,cSCC ,cutaneous squamous cell carcinoma ,gene expression profiling ,immunotherapy ,nanostring ,Immunologic diseases. Allergy ,RC581-607 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Cemiplimab has demonstrated relevant clinical activity in cutaneous squamous cell carcinoma (cSCC) but mechanisms of primary and acquired resistance to immunotherapy are still unknown. We collected clinical data from locally advanced and/or metastatic cSSC patients treated with cemiplimab in two Italian University centers. In addition, gene expression analysis by using Nanostring Technologies platform to evaluate 770 cancer- and immune-related genes on 20 tumor tissue samples (9 responders and 11 non-responders to cemiplimab) was performed. We enrolled 81 patients with a median age of 82 years. After 16.4 months of median follow-up, 12- and 24-months PFS were 53% and 42%, respectively; while 12- and 24-months OS were 71% and 61%, respectively. Treatment was well tolerated. Overall response rate (ORR) was 58%, with a disease control rate (DCR) of 77.8%. The difference between genes expressed in responder versus non-responder patient samples was substantial, particularly for genes involved in immune system regulation. Cemiplimab-resistant tumors were associated with over-expression of CCL-20 and CXCL-8. Cemiplimab confirmed efficacy and safety data in real-life cSCC patients. Overexpression of CCL-20 and CXCL-8 could represent biomarkers of lack of response to immunotherapy.
- Published
- 2024
- Full Text
- View/download PDF
21. Exploring the multifaceted antitumor activity of axitinib in lung carcinoids
- Author
-
Monica Oldani, Maria Celeste Cantone, Germano Gaudenzi, Silvia Carra, Alessandra Dicitore, Davide Saronni, Maria Orietta Borghi, Angela Lombardi, Michele Caraglia, Luca Persani, and Giovanni Vitale
- Subjects
lung carcinoid ,tyrosine kinase inhibitors ,axitinib ,cell cycle ,senescence ,mitotic catastrophe ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
IntroductionLung carcinoids (LCs) are a type of neuroendocrine tumor (NET) that originate in the bronchopulmonary tract. LCs account for 20–25% of all NETs and approximately 1–2% of lung cancers. Given the highly vascularized nature of NETs and their tendency to overexpress vascular growth factor receptors (VEGFR), inhibiting angiogenesis appears as a potential therapeutic target in slowing down tumor growth and spread. This study evaluated the long-term antitumor activity and related mechanisms of axitinib (AXI), a VEGFR-targeting drug, in LC cell lines.MethodsThree LC cell lines (NCI-H727, UMC-11 and NCI-H835) were incubated with their respective EC50 AXI concentrations for 6 days. At the end of the incubation, FACS experiments and Western blot analyses were performed to examine changes in the cell cycle and the activation of apoptosis. Microscopy analyses were added to describe the mechanisms of senescence and mitotic catastrophe when present.ResultsThe primary effect of AXI on LC cell lines is to arrest tumor growth through an indirect DNA damage. Notably, AXI triggers this response in diverse manners among the cell lines, such as inducing senescence or mitotic catastrophe. The drug seems to lose its efficacy when the DNA damage is mitigated, as observed in NCI-H835 cells.ConclusionThe ability of AXI to affect cell viability and proliferation in LC tumor cells highlights its potential as a therapeutic agent. The role of DNA damage and the consequent activation of senescence seem to be a prerequisite for AXI to exert its function.
- Published
- 2024
- Full Text
- View/download PDF
22. “False friends” in Language Subcortical Mapping: A Systematic Literature Review
- Author
-
Marino, Salvatore, Menna, Grazia, Bilgin, Lal, Mattogno, Pier Paolo, Gaudino, Simona, Quaranta, Davide, Caraglia, Naike, Olivi, Alessandro, Berger, Mitchel S., Doglietto, Francesco, and Della Pepa, Giuseppe Maria
- Published
- 2024
- Full Text
- View/download PDF
23. Previous radiotherapy increases the efficacy of cemiplimab in the treatment of locally advanced and metastatic cutaneous squamous cell carcinoma: A retrospective analysis
- Author
-
Nardone, Valerio, Napolitano, Stefania, Gagliardi, Federico, Esposito, Alfonso, Caraglia, Francesco, Briatico, Giulia, Scharf, Camila, Ronchi, Andrea, D'Onofrio, Ida, D'Ippolito, Emma, Russo, Anna, Belfiore, Maria Paola, Franco, Renato, Argenziano, Giuseppe, Ciardiello, Fortunato, Reginelli, Alfonso, Cappabianca, Salvatore, and Troiani, Teresa
- Published
- 2024
- Full Text
- View/download PDF
24. A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario
- Author
-
Giuseppe Di Lorenzo, Aieta Michele, Leo Silvana, Domenico Bilancia, Rossella Di Trolio, Michela Rosaria Iuliucci, Concetta Ingenito, Roberta Rubino, Arianna Piscosquito, Michele Caraglia, Marianna Donnarumma, Ferdinando Costabile, Raffaele Conca, Marco Pisino, Angelo Vaia, Luca Scafuri, Antonio Verde, and Carlo Buonerba
- Subjects
Cemiplimab ,Squamous cell carcinoma ,Clinical response ,Adverse reactions ,Distant metastasis ,Survival outcomes ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Introduction This retrospective study investigates the efficacy of cemiplimab, a monoclonal antibody targeting the PD-1 receptor, in treating squamous cell carcinoma (SCC) of the skin. Methods The study analyzes data from 50 patients with SCC, focusing on various clinical parameters, including patient demographics, tumor characteristics, treatment history, disease status at the beginning of therapy, and survival outcomes. Results Of the patients who received at least one cycle of cemiplimab, 42% showed a clinical response. Adverse reactions were generally low, with the safety profile deemed excellent. During a median follow-up of 9.6 months, 17 patients experienced progression or death. Among these, 15 patients had died at the time of the analysis. The median progression-free survival (PFS) for the entire cohort was approximately 20.8 months, while median overall survival (OS) was not reached. Univariate Cox regression analysis for PFS showed that tumors in the arms and legs were associated with higher progression risk, while age above 65 years was not statistically significant. Distant metastasis exhibited a trend towards improved PFS. In terms of OS, distant metastasis was a significant predictor of reduced survival, while age above 65 years was not statistically significant. In a multivariate model, only the absence of distant metastasis remained significant, with an adjusted odds ratio (OR) of 12.3 (95% confidence interval 1.3–112.1). Conclusion These findings provide valuable insights into the real-world effectiveness of cemiplimab in SCC management.
- Published
- 2023
- Full Text
- View/download PDF
25. Sexuality Education in Italy 2016-2020: A National Survey Investigating Coverage, Content and Evaluation of School-Based Educational Activities
- Author
-
Chinelli, Alice, Salfa, Maria Cristina, Cellini, Andrea, Ceccarelli, Luca, Farinella, Massimo, Rancilio, Laura, Galipò, Rosario, Meli, Paolo, Camposeragna, Antonella, Colaprico, Ludovica, Oldrini, Massimo, Ubbiali, Marco, Caraglia, Anna, Martinelli, Domenico, Mortari, Luigina, Palamara, Anna Teresa, Suligoi, Barbara, and Tavoschi, Lara
- Abstract
Comprehensive sexuality education is an important means of promoting sexual well-being amongst young people and is key to preventing sexually transmitted infections (STIs). However, sexuality education is not currently included in the formal curriculum in Italian schools. The aim of this study was to develop an inventory of school-based sexuality education (SBSE) activities carried out by external providers and implemented in Italy from 2016 to 2020. A desk review and survey were carried out. In the desk review online documents on STI prevention were analysed. The survey investigated the providers, objectives, content and methods used to implement SBSE activities in secondary schools. Findings revealed a highly heterogeneous situation in terms of geographical coverage, service providers, objectives and evaluation. Some SBSE activities were classified as adopting a comprehensive approach to sexuality education, while the majority focused on STI prevention, and many were single-session activities. Although most activities were said to have been evaluated no results were available. The data showed that SBSE is not systematically and equally delivered across Italy. Action is needed to provide young people with evidence-based, age-appropriate and accurate education about sexual and reproductive health and wellbeing.
- Published
- 2023
- Full Text
- View/download PDF
26. Whole-genome analysis suggesting probiotic potential and safety properties of Pediococcus pentosaceus DSPZPP1, a promising LAB strain isolated from traditional fermented sausages of the Basilicata region (Southern Italy)
- Author
-
Madhura S. Tathode, Maria Grazia Bonomo, Silvia Zappavigna, Stefania Mirela Mang, Marco Bocchetti, Ippolito Camele, Michele Caraglia, and Giovanni Salzano
- Subjects
Pediococcus pentosaceus ,probiotics ,whole genome sequencing ,antimicrobial resistance ,bacteriocins ,Microbiology ,QR1-502 - Abstract
IntroductionMany lactic acid bacteria (LAB) strains are currently gaining attention in the food industry and various biological applications because of their harmless and functional properties. Given the growing consumer demand for safe food, further research into potential probiotic bacteria is beneficial. Therefore, we aimed to characterize Pediococcus pentosaceus DSPZPP1, a LAB strain isolated from traditional fermented sausages from the Basilicata region of Southern Italy.MethodsIn this study, we analyzed the whole genome of the P. pentosaceus DSPZPP1 strain and performed in silico characterization to evaluate its applicability for probiotics and use in the food industry.Results and DiscussionThe whole-genome assembly and functional annotations revealed many interesting characteristics of the DSPZPP1 strain. Sequencing raw reads were assembled into a draft genome of size 1,891,398 bp, with a G + C content of 37.3%. Functional annotation identified 1930 protein-encoding genes and 58 RNAs including tRNA, tmRNA, and 16S, 23S, and 5S rRNAs. The analysis shows the presence of genes that encode water-soluble B-group vitamins such as biotin, folate, coenzyme A, and riboflavin. Furthermore, the analysis revealed that the DSPZPP1 strain can synthesize class II bacteriocin, penocin A, adding importance to the food industry for bio-enriched food. The DSPZPP1 genome does not show the presence of plasmids, and no genes associated with antimicrobial resistance and virulence were found. In addition, two intact bacteriophages were identified. Importantly, the lowest probability value in pathogenicity analysis indicates that this strain is non-pathogenic to humans. 16 s rRNA-based phylogenetic analysis and comparative analysis based on ANI and Tetra reveal that the DSPZPP1 strain shares the closest evolutionary relationship with P. pentosaceus DSM 20336 and other Pediococcus strains. Analysis of carbohydrate active enzymes (CAZymes) identified glycosyl transferases (GT) as a main class of enzymes followed by glycoside hydrolases (GH). Our study shows several interesting characteristics of the isolated DSPZPP1 strain from fermented Italian sausages, suggesting its potential use as a promising probiotic candidate and making it more appropriate for selection as a future additive in biopreservation.
- Published
- 2024
- Full Text
- View/download PDF
27. MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer
- Author
-
Alessia Maria Cossu, Federica Melisi, Teresa Maria Rosaria Noviello, Lucia Stefania Pasquale, Piera Grisolia, Carla Reale, Marco Bocchetti, Michela Falco, Chiara Tammaro, Nunzio Accardo, Francesco Longo, Salvatore Allosso, Massimo Mesolella, Raffaele Addeo, Francesco Perri, Alessandro Ottaiano, Filippo Ricciardiello, Evzen Amler, Concetta Ambrosino, Gabriella Misso, Michele Ceccarelli, Michele Caraglia, and Marianna Scrima
- Subjects
MT: non-coding RNAs ,microRNAs ,gene expression ,LSCC ,metastases miR-449a ,IL-6 trans-signaling ,Therapeutics. Pharmacology ,RM1-950 - Abstract
MicroRNAs (miRNAs) are involved in post-transcriptional gene expression regulation and in mechanisms of cancer growth and metastases. In this light, miRNAs could be promising therapeutic targets and biomarkers in clinical practice. Therefore, we investigated if specific miRNAs and their target genes contribute to laryngeal squamous cell carcinoma (LSCC) development. We found a significant decrease of miR-449a in LSCC patients with nodal metastases (63.3%) compared with patients without nodal involvement (44%). The AmpliSeq Transcriptome of HNO-210 miR-449a-transfected cell lines allowed the identification of IL6-R as a potential target. Moreover, the downregulation of IL6-R and the phosphorylation reduction of the downstream signaling effectors, suggested the inhibition of the IL-6 trans-signaling pathway. These biochemical effects were paralleled by a significant inhibition of invasion and migration in vitro and in vivo, supporting an involvement of epithelial-mesenchymal transition. These findings indicate that miR-449a contributes to suppress the metastasization of LSCC by the IL-6 trans-signaling block and affects sensitivity to external stimuli that mimic pro-inflammatory conditions.
- Published
- 2024
- Full Text
- View/download PDF
28. MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes
- Author
-
C. Giallongo, I. Dulcamare, S. Giallongo, A. Duminuco, D. Pieragostino, M. C. Cufaro, A. M. Amorini, G. Lazzarino, A. Romano, N. Parrinello, M. Di Rosa, G. Broggi, R. Caltabiano, M. Caraglia, M. Scrima, L. S. Pasquale, M. S. Tathode, G. Li Volti, R. Motterlini, F. Di Raimondo, D. Tibullo, and G. A. Palumbo
- Subjects
Cytology ,QH573-671 - Abstract
Abstract Ineffective hematopoiesis is a hallmark of myelodysplastic syndromes (MDS). Hematopoietic alterations in MDS patients strictly correlate with microenvironment dysfunctions, eventually affecting also the mesenchymal stromal cell (MSC) compartment. Stromal cells are indeed epigenetically reprogrammed to cooperate with leukemic cells and propagate the disease as “tumor unit”; therefore, changes in MSC epigenetic profile might contribute to the hematopoietic perturbations typical of MDS. Here, we unveil that the histone variant macroH2A1 (mH2A1) regulates the crosstalk between epigenetics and inflammation in MDS-MSCs, potentially affecting their hematopoietic support ability. We show that the mH2A1 splicing isoform mH2A1.1 accumulates in MDS-MSCs, correlating with the expression of the Toll-like receptor 4 (TLR4), an important pro-tumor activator of MSC phenotype associated to a pro-inflammatory behavior. MH2A1.1-TLR4 axis was further investigated in HS-5 stromal cells after ectopic mH2A1.1 overexpression (mH2A1.1-OE). Proteomic data confirmed the activation of a pro-inflammatory signature associated to TLR4 and nuclear factor kappa B (NFkB) activation. Moreover, mH2A1.1-OE proteomic profile identified several upregulated proteins associated to DNA and histones hypermethylation, including S-adenosylhomocysteine hydrolase, a strong inhibitor of DNA methyltransferase and of the methyl donor S-adenosyl-methionine (SAM). HPLC analysis confirmed higher SAM/SAH ratio along with a metabolic reprogramming. Interestingly, an increased LDHA nuclear localization was detected both in mH2A1.1-OE cells and MDS-MSCs, probably depending on MSC inflammatory phenotype. Finally, coculturing healthy mH2A1.1-OE MSCs with CD34+ cells, we found a significant reduction in the number of CD34+ cells, which was reflected in a decreased number of colony forming units (CFU-Cs). These results suggest a key role of mH2A1.1 in driving the crosstalk between epigenetic signaling, inflammation, and cell metabolism networks in MDS-MSCs.
- Published
- 2023
- Full Text
- View/download PDF
29. Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer
- Author
-
Marianna Abate, Angela Lombardi, Amalia Luce, Manuela Porru, Carlo Leonetti, Marco Bocchetti, Virginia Campani, Giuseppe De Rosa, Sossio Fabio Graziano, Valeria Nele, Francesco Cardile, Federica Zito Marino, Renato Franco, Andrea Ronchi, Marianna Scrima, Rossella Sperlongano, Roberto Alfano, Gabriella Misso, Evzen Amler, Michele Caraglia, and Silvia Zappavigna
- Subjects
MT: Delivery Strategies ,nanodiamonds ,MicroRNA ,breast cancer ,gene delivery ,nanomedicine ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Nanodiamonds are innovative nanocrystalline carbon particles able to deliver chemically conjugated miRNAs. In oncology, the use of miRNA-based therapies may represent an advantage, based on their ability to simultaneously target multiple intracellular oncogenic targets. Here, nanodiamonds were tested and optimized to deliver miR-34a, a miRNA playing a key role in inhibiting tumor development and progression in many cancers. The physical-chemical properties of nanodiamonds were investigated suggesting electrical stability and uniformity of structure and size. Moreover, we evaluated nanodiamond cytotoxicity on two breast cancer cell models and confirmed their excellent biocompatibility. Subsequently, nanodiamonds were conjugated with miR-34a, using the chemical crosslinker polyethyleneimine; real-time PCR analysis revealed a higher level of miR-34a in cancer cells treated with the different formulations of nanodiamonds than with commercial transfectant. A significant and early nanodiamond-miR-34a uptake was recorded by FACS and fluorescence microscopy analysis in MCF7 and MDA-MB-231 cells. Moreover, nanodiamond-miR-34a significantly inhibited both cell proliferation and migration. Finally, a remarkable anti-tumor effect of miR-34a-conjugated nanodiamonds was observed in both heterotopic and orthotopic murine xenograft models. In conclusion, this study provides a rationale for the development of new therapeutic strategies based on use of miR-34a delivered by nanodiamonds to improve the clinical treatment of neoplasms.
- Published
- 2023
- Full Text
- View/download PDF
30. MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer
- Author
-
Cossu, Alessia Maria, Melisi, Federica, Noviello, Teresa Maria Rosaria, Pasquale, Lucia Stefania, Grisolia, Piera, Reale, Carla, Bocchetti, Marco, Falco, Michela, Tammaro, Chiara, Accardo, Nunzio, Longo, Francesco, Allosso, Salvatore, Mesolella, Massimo, Addeo, Raffaele, Perri, Francesco, Ottaiano, Alessandro, Ricciardiello, Filippo, Amler, Evzen, Ambrosino, Concetta, Misso, Gabriella, Ceccarelli, Michele, Caraglia, Michele, and Scrima, Marianna
- Published
- 2024
- Full Text
- View/download PDF
31. Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-Metabolism
- Author
-
Vincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, Carlo Maurea, Domenico Gabrielli, Luigi Tarantini, Andrea Paccone, Alessandro Inno, Stefano Oliva, Christian Cadeddu Dessalvi, Concetta Zito, Michele Caraglia, Massimiliano Berretta, Giuseppe D’Aiuto, and Nicola Maurea
- Subjects
cancer ,cardio-oncology ,COVID-19 ,cardiotoxicity ,inflammation ,metabolism ,Biology (General) ,QH301-705.5 - Abstract
Cardiovascular disease and cancer are the two leading causes of morbidity and mortality in the world. The emerging field of cardio-oncology described several shared risk factors that predispose patients to both cardiovascular disease and cancer. Post-acute COVID-19 syndrome is a chronic condition that occurs in many patients who have experienced a SARS-CoV-2 infection, mainly based on chronic fatigue, sedentary lifestyle, cramps, breathing difficulties, and reduced lung performance. Post-acute COVID-19 exposes patients to increased visceral adiposity, insulin resistance, myosteatosis, and white adipose tissue content (surrounded by M1 macrophages and characterized by a Th1/Th17 phenotype), which increases the risk of cardiovascular mortality and cancer recurrence. In this review, the main metabolic affections of post-acute COVID-19 syndrome in cancer patients at low and high risk of cardiomyopathies will be summarized. Furthermore, several non-pharmacological strategies aimed at reducing atherosclerotic and cardiac risk will be provided, especially through anti-inflammatory nutrition with a low insulin and glycemic index, appropriate physical activity, and immune-modulating bioactivities able to reduce visceral obesity and myosteatosis, improving insulin-related signaling and myocardial metabolism.
- Published
- 2024
- Full Text
- View/download PDF
32. TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities
- Author
-
Morena Fasano, Mario Pirozzi, Chiara Carmen Miceli, Mariateresa Cocule, Michele Caraglia, Mariarosaria Boccellino, Pasquale Vitale, Vincenzo De Falco, Stefano Farese, Alessia Zotta, Fortunato Ciardiello, and Raffaele Addeo
- Subjects
angiogenesis ,colorectal cancer ,EMT ,microenvironment ,TGF-β ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide, with 20% of patients presenting with metastatic disease at diagnosis. TGF-β signaling plays a crucial role in various cellular processes, including growth, differentiation, apoptosis, epithelial-mesenchymal transition (EMT), regulation of the extracellular matrix, angiogenesis, and immune responses. TGF-β signals through SMAD proteins, which are intracellular molecules that transmit TGF-β signals from the cell membrane to the nucleus. Alterations in the TGF-β pathway and mutations in SMAD proteins are common in metastatic CRC (mCRC), making them critical factors in CRC tumorigenesis. This review first analyzes normal TGF-β signaling and then investigates its role in CRC pathogenesis, highlighting the mechanisms through which TGF-β influences metastasis development. TGF-β promotes neoangiogenesis via VEGF overexpression, pericyte differentiation, and other mechanisms. Additionally, TGF-β affects various elements of the tumor microenvironment, including T cells, fibroblasts, and macrophages, promoting immunosuppression and metastasis. Given its strategic role in multiple processes, we explored different strategies to target TGF-β in mCRC patients, aiming to identify new therapeutic options.
- Published
- 2024
- Full Text
- View/download PDF
33. A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer
- Author
-
Pilar Chacon-Millan, Stefania Lama, Nunzio Del Gaudio, Antonietta Gerarda Gravina, Alessandro Federico, Raffaele Pellegrino, Amalia Luce, Lucia Altucci, Angelo Facchiano, Michele Caraglia, and Paola Stiuso
- Subjects
competing endogenous RNA ,ulcerative colitis ,colorectal cancer ,miRNA ,biomarkers inflammatory bowel disease ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Ulcerative colitis (UC), an inflammatory bowel disease (IBD), may increase the risk of colorectal cancer (CRC) by activating chronic proinflammatory pathways. The goal of this study was to find serum prediction biomarkers in UC to CRC development by combining low-density miRNA microarray and biocomputational approaches. The UC and CRC miRNA expression profiles were compared by low-density miRNA microarray, finding five upregulated miRNAs specific to UC progression to CRC (hsa-let-7d-5p, hsa-miR-16-5p, hsa-miR-145-5p, hsa-miR-223-5p, and hsa-miR-331-3p). The circRNA/miRNA/mRNA competitive endogenous RNA (ceRNA) network analysis showed that the candidate miRNAs were connected to well-known colitis-associated CRC ACVR2A, SOCS1, IGF2BP1, FAM126A, and CCDC85C mRNAs, and circ-SHPRH circRNA. SST and SCARA5 genes regulated by hsa-let-7d-5p, hsa-miR-145-5p, and hsa-miR-331-3p were linked to a poor survival prognosis in a CRC patient dataset from The Cancer Genome Atlas (TCGA). Lastly, our mRNA and miRNA candidates were validated by comparing their expression to differentially expressed mRNAs and miRNAs from colitis-associated CRC tissue databases. A high level of hsa-miR-331-3p and a parallel reduction in SOCS1 mRNA were found in tissue and serum. We propose hsa-miR-331-3p and possibly hsa-let-7d-5p as novel serum biomarkers for predicting UC progression to CRC. More clinical sample analysis is required for further validation.
- Published
- 2024
- Full Text
- View/download PDF
34. The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review
- Author
-
Nardone, Valerio, Romeo, Caterina, D’Ippolito, Emma, Pastina, Pierpaolo, D’Apolito, Maria, Pirtoli, Luigi, Caraglia, Michele, Mutti, Luciano, Bianco, Giovanna, Falzea, Antonella Consuelo, Giannicola, Rocco, Giordano, Antonio, Tagliaferri, Pierosandro, Vinciguerra, Claudia, Desideri, Isacco, Loi, Mauro, Reginelli, Alfonso, Cappabianca, Salvatore, Tassone, Pierfrancesco, and Correale, Pierpaolo
- Published
- 2023
- Full Text
- View/download PDF
35. MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine
- Author
-
Elisa Martino, Nunzia D’Onofrio, Camilla Anastasio, Marianna Abate, Silvia Zappavigna, Michele Caraglia, and Maria Luisa Balestrieri
- Subjects
MT: Non-coding RNAs ,miRNAs ,nanoparticles ,theranostics ,nanomedicine ,cancer ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Micro-RNAs (miRNAs) control gene expression at the post-transcriptional level and are widely involved in carcinogenesis, playing a role as both oncogenes and tumor suppressors. MiRNAs act as potent therapeutic weapon in cancer, but their potential therapeutic use is limited by the off-target effect due to their nonspecific distribution in normal tissues. The encapsulation of miRNAs in nanostructured carriers allows targeted effects aimed to destroy cancer cells, without affecting healthy tissues. Due to their small size and the optimal surface/size ratio, nanoparticles (NPs) envelop, protect, and release miRNAs, representing a promising strategy in cancer treatment. In the present review, we discuss the latest advances in the field of miRNA-encapsulating NPs in cancer, focusing on colorectal cancer and its metastatic forms, one of the most common malignancies worldwide.
- Published
- 2023
- Full Text
- View/download PDF
36. Editorial: Type 2 diabetes and cancer: clinical and molecular interactions
- Author
-
Mariachiara Santorsola, Michele Caraglia, and Alessandro Ottaiano
- Subjects
diabetes ,genetics ,cancer ,p53 ,lung cancer ,glioma ,Medicine (General) ,R5-920 - Published
- 2024
- Full Text
- View/download PDF
37. Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocol
- Author
-
Ira H. Haraldsen, Christoffer Hatlestad-Hall, Camillo Marra, Hanna Renvall, Fernando Maestú, Jorge Acosta-Hernández, Soraya Alfonsin, Vebjørn Andersson, Abhilash Anand, Victor Ayllón, Aleksandar Babic, Asma Belhadi, Cindy Birck, Ricardo Bruña, Naike Caraglia, Claudia Carrarini, Erik Christensen, Americo Cicchetti, Signe Daugbjerg, Rossella Di Bidino, Ana Diaz-Ponce, Ainar Drews, Guido Maria Giuffrè, Jean Georges, Pedro Gil-Gregorio, Dianne Gove, Tim M. Govers, Harry Hallock, Marja Hietanen, Lone Holmen, Jaakko Hotta, Samuel Kaski, Rabindra Khadka, Antti S. Kinnunen, Anne M. Koivisto, Shrikanth Kulashekhar, Denis Larsen, Mia Liljeström, Pedro G. Lind, Alberto Marcos Dolado, Serena Marshall, Susanne Merz, Francesca Miraglia, Juha Montonen, Ville Mäntynen, Anne Rita Øksengård, Javier Olazarán, Teemu Paajanen, José M. Peña, Luis Peña, Daniel lrabien Peniche, Ana S. Perez, Mohamed Radwan, Federico Ramírez-Toraño, Andrea Rodríguez-Pedrero, Timo Saarinen, Mario Salas-Carrillo, Riitta Salmelin, Sonia Sousa, Abdillah Suyuthi, Mathias Toft, Pablo Toharia, Thomas Tveitstøl, Mats Tveter, Ramesh Upreti, Robin J. Vermeulen, Fabrizio Vecchio, Anis Yazidi, and Paolo Maria Rossini
- Subjects
mild cognitive impairment ,dementia ,machine learning ,artificial intelligence ,electroencephalography (EEG) ,magnetoencephalography (MEG) ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
More than 10 million Europeans show signs of mild cognitive impairment (MCI), a transitional stage between normal brain aging and dementia stage memory disorder. The path MCI takes can be divergent; while some maintain stability or even revert to cognitive norms, alarmingly, up to half of the cases progress to dementia within 5 years. Current diagnostic practice lacks the necessary screening tools to identify those at risk of progression. The European patient experience often involves a long journey from the initial signs of MCI to the eventual diagnosis of dementia. The trajectory is far from ideal. Here, we introduce the AI-Mind project, a pioneering initiative with an innovative approach to early risk assessment through the implementation of advanced artificial intelligence (AI) on multimodal data. The cutting-edge AI-based tools developed in the project aim not only to accelerate the diagnostic process but also to deliver highly accurate predictions regarding an individual's risk of developing dementia when prevention and intervention may still be possible. AI-Mind is a European Research and Innovation Action (RIA H2020-SC1-BHC-06-2020, No. 964220) financed between 2021 and 2026. First, the AI-Mind Connector identifies dysfunctional brain networks based on high-density magneto- and electroencephalography (M/EEG) recordings. Second, the AI-Mind Predictor predicts dementia risk using data from the Connector, enriched with computerized cognitive tests, genetic and protein biomarkers, as well as sociodemographic and clinical variables. AI-Mind is integrated within a network of major European initiatives, including The Virtual Brain, The Virtual Epileptic Patient, and EBRAINS AISBL service for sensitive data, HealthDataCloud, where big patient data are generated for advancing digital and virtual twin technology development. AI-Mind's innovation lies not only in its early prediction of dementia risk, but it also enables a virtual laboratory scenario for hypothesis-driven personalized intervention research. This article introduces the background of the AI-Mind project and its clinical study protocol, setting the stage for future scientific contributions.
- Published
- 2024
- Full Text
- View/download PDF
38. MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes
- Author
-
Giallongo, C., Dulcamare, I., Giallongo, S., Duminuco, A., Pieragostino, D., Cufaro, M. C., Amorini, A. M., Lazzarino, G., Romano, A., Parrinello, N., Di Rosa, M., Broggi, G., Caltabiano, R., Caraglia, M., Scrima, M., Pasquale, L. S., Tathode, M. S., Li Volti, G., Motterlini, R., Di Raimondo, F., Tibullo, D., and Palumbo, G. A.
- Published
- 2023
- Full Text
- View/download PDF
39. From images to words: a proposal for a playful methodology of Italian L2 through the silent book
- Author
-
Deborah Caraglia
- Subjects
lower-secondary school ,teaching italian as l2/fl ,ludic approach to teaching ,visual education ,silenti book ,Theory and practice of education ,LB5-3640 ,Romanic languages ,PC1-5498 - Abstract
The increasing complexity the Italian educational environment, often made up of multilingual, multicultural and multilevel classes, requires effective ways of developing and strengthening the Italian language in students with an immigrant background. It should be a path of growth and sharing, useful and stimulating at the same time, capable of motivating students. Hence, the paper presents a didactic proposal based on a ludic methodology and the use of a new tool in the Italian educational context: the silent book.
- Published
- 2023
- Full Text
- View/download PDF
40. Psychological Distress Affects Performance during Exercise-Based Cardiac Rehabilitation
- Author
-
Marta Ricci, Gino Pozzi, Naike Caraglia, Daniela P. R. Chieffo, Daniela Polese, and Leonarda Galiuto
- Subjects
cardiac rehabilitation ,psychological distress ,depression ,anxiety ,Science - Abstract
Background: It is known that psychosocial distress affects the morbidity and mortality of patients with cardiovascular disease of every age. The aim of this study was to produce novel information on how psychological distress can influence cardiovascular performance in patients after cardiac surgery undergoing multidisciplinary cardiac rehabilitation. Methods: Patients (n = 57) admitted after cardiac surgery for valvular or coronary disease underwent, within 5 days of admission, the Symptom Checklist-90-Revised (SCL-90-R) self-report questionnaire to measure psychiatric symptoms and the 12-item General Health Questionnaire (GHQ-12) to assess the level of psychological distress. The Positive Symptom Distress Index (PSDI) was measured to indicate the amplitude of symptom distress. Cardiovascular performance was assessed by a 6 min walking test (6MWT) at admission and discharge, and oxygen consumption (VO2 max) was derived. Results: Within the SCL-90-R score, somatic symptoms (47.4%), depressive and anxiety symptoms (36.8% and 33.3%, respectively), symptoms of phobic anxiety (21.1%), and psychoticism (24.6%) were over-represented. As for the GHQ-12, 75.4% of the sample reported an abnormally negative perception of their health status. An inverse correlation was shown between the variation in 6MWT and SCL depression (p = 0.048), PSDI (p = 0.022), and the GHQ-12 (p = 0.040). Similarly, an inverse correlation was shown between the variation in the VO2 max, GHQ-12 (p = 0.041), and the PSDI (p = 0.023). Conclusions: Post-cardiac surgery cardiac rehabilitation was associated with increased symptoms of psychological discomfort, as compared with the general population. The amplitude of psychological distress, depression, and hostility are associated with limited improvement in performance. These data strengthen the need for psychological support during cardiac rehabilitation programs.
- Published
- 2024
- Full Text
- View/download PDF
41. Neuropsychological predictors of conversion from mild cognitive impairment to dementia at different timepoints
- Author
-
Davide Quaranta, Naike Caraglia, Federica L'Abbate, Guido Maria Giuffrè, Valeria Guglielmi, Giovanna Masone Iacobucci, Paolo Maria Rossini, Paolo Calabresi, and Camillo Marra
- Subjects
Alzheimer's disease ,episodic memory and semantic memory ,mild cognitive impairment ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Abstract Introduction : Impairment of episodic memory is largely considered the main cognitive marker of prodromic Alzheimer's disease (AD). Nevertheless, the neuropathological process in AD starts several years before and, apart from biomarkers well defined in the Amyloid (A), Tauopathy (T), Neurodegeneration (N) framework, early clinical and neuropsychological markers able to detect mild cognitive impairment (MCI) due to AD before the appearance of memory disorders are lacking in clinical practice. Investigations on semantic memory have shown promising results in providing an earlier marker of dementia in MCI patients. Methods : A total of 253 MCI subjects were followed up every 6 months for 6 years—186 converted to dementia and 67 remained stable at the sixth year of follow‐up. Twenty‐seven patients progressed in the first 2 years (fast converters), 107 in the third to fourth year (intermediate converters), and 51 after the fourth year of follow‐up (slow converters). Results : Stable MCI subjects performed better than fast decliners in Mini–Mental State Examination (MMSE), several long‐term memory scores, and category verbal fluency test (CFT); stable and intermediate converters differ only in MMSE and CFT tests; and stable and slow converters differ only in MMSE and phonological/semantic discrepancy score. Conclusion : Early impairment of semantic memory could predict the evolution to AD before the onset of episodic memory disorders, and the discrepancy between phonological and semantic verbal fluency could be able to detect this impairment in advance in respect of simple CFT tests. The assessment of different aspects of semantic memory and its degradation could represent an early cognitive marker to intercept MCI due to AD in clinical practice.
- Published
- 2023
- Full Text
- View/download PDF
42. MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine
- Author
-
Martino, Elisa, D’Onofrio, Nunzia, Anastasio, Camilla, Abate, Marianna, Zappavigna, Silvia, Caraglia, Michele, and Balestrieri, Maria Luisa
- Published
- 2023
- Full Text
- View/download PDF
43. Early Estimates of Monkeypox Incubation Period, Generation Time, and Reproduction Number, Italy, May-June 2022
- Author
-
Guzzetta, Giorgio, Mammone, Alessia, Ferraro, Federica, Caraglia, Anna, Rapiti, Alessia, Marziano, Valentina, Poletti, Piero, Cereda, Danilo, Vairo, Francesco, Mattei, Giovanna, Maraglino, Francesco, Rezza, Giovanni, and Merler, Stefano
- Subjects
Human monkeypox -- Diagnosis -- Physiological aspects -- Development and progression ,Infectious disease incubation period -- Analysis ,Health - Abstract
After the first reports of autochthonous cases of monkeypox (MPX) in Europe at the beginning of May, the World Health Organization (WHO) and the European Centre for Disease Prevention and [...]
- Published
- 2022
- Full Text
- View/download PDF
44. An innovative measure architecture to monitor civil infrastructures
- Author
-
Germano, Federico, Rigon, Alberto, and Caraglia, Francesco
- Published
- 2023
- Full Text
- View/download PDF
45. Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer
- Author
-
Abate, Marianna, Lombardi, Angela, Luce, Amalia, Porru, Manuela, Leonetti, Carlo, Bocchetti, Marco, Campani, Virginia, De Rosa, Giuseppe, Graziano, Sossio Fabio, Nele, Valeria, Cardile, Francesco, Marino, Federica Zito, Franco, Renato, Ronchi, Andrea, Scrima, Marianna, Sperlongano, Rossella, Alfano, Roberto, Misso, Gabriella, Amler, Evzen, Caraglia, Michele, and Zappavigna, Silvia
- Published
- 2023
- Full Text
- View/download PDF
46. Early Estimates of Monkeypox Incubation Period, Generation Time, and Reproduction Number, Italy, May–June 2022
- Author
-
Giorgio Guzzetta, Alessia Mammone, Federica Ferraro, Anna Caraglia, Alessia Rapiti, Valentina Marziano, Piero Poletti, Danilo Cereda, Francesco Vairo, Giovanna Mattei, Francesco Maraglino, Giovanni Rezza, and Stefano Merler
- Subjects
monkeypox ,reproduction number ,generation time ,incubation period ,MPX ,MPXV ,Medicine ,Infectious and parasitic diseases ,RC109-216 - Abstract
We analyzed the first 255 PCR-confirmed cases of monkeypox in Italy in 2022. Preliminary estimates indicate mean incubation period of 9.1 (95% CI 6.5–10.9) days, mean generation time of 12.5 (95% CI 7.5–17.3) days, and reproduction number among men who have sex with men of 2.43 (95% CI 1.82–3.26).
- Published
- 2022
- Full Text
- View/download PDF
47. The Art of Counseling in the Treatment of Head and Neck Cancer: Exploratory Investigation among Perceptions of Health Professionals in Southern Italy
- Author
-
Raffaele Addeo, Luca Pompella, Pasquale Vitale, Silvia Ileana Sara Fattoruso, Ilaria Di Giovanni, Francesco Perri, Michele Caraglia, Morena Fasano, and Raffaele Arigliani
- Subjects
metastatic squamous cell carcinoma of the head and neck ,counseling ,open communication ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
(1) Background: Recurrent and/or metastatic patients with head and neck squamous cell carcinoma show a poor prognosis, which has not changed significantly in 30 years. Preserving quality of life is a primary goal for this subset of patients; (2) Methods: A group of 19 physicians working in South Italy and daily involved in head and neck cancer care took an anonymous online survey aimed at revealing the level of knowledge and the application of communication techniques in daily patient care; (3) Results: Several specialists, 18 out 19 (95%), considered that patient participation in therapeutic choices is mandatory. The main obstacles to complete and reciprocate communication still consist of lack of time and staff, but also in the need for greater organization, which goes beyond the multidisciplinary strategy already used; (4) Conclusions: A greater impulse to training and updating on issues related to counseling can improve communication between the different clinicians involved in the treatment plan.
- Published
- 2022
- Full Text
- View/download PDF
48. SARS-COV-2 SURVEILLANCE IN LONG-TERM CARE FACILITIES: FEASIBILITY AND OUTCOMES OF AN ITALIAN WEEKLY-BASED SERVICE
- Author
-
C. Damiano, M. Sabbatucci, G. Onder, C. Lo Noce, M. Barbalace, A. Caraglia, and C. Giacomozzi
- Subjects
Infectious and parasitic diseases ,RC109-216 - Abstract
Intro: A weekly-based service was hypothesized as feasible and usable for surveillance, to monitoring cases in Long-Term Care Facilities (LTCFs) in the SARS-CoV-2 emergency in Italy. Methods: A web-based platform was set-up at the Italian National Institute of Health (ISS) at mid-2020. Protocols were validated and people trained to guarantee the delivery of a reliable weekly report to the Reference person of each participating Region, including the most relevant SARS-CoV-2 data and criticalities, i.e. new infections and outbreaks, deaths, hospitalization, isolations, vaccination coverage (VC), personal protective equipment and swabs. Findings: The service has been working at regimen since October 2020, available 24/7, the ISS database being fed by 7 Regions. In the period January 2021 – June 2022, 852 LCTFs (with over 22.000 residents) contributed to the service, with high adherence rate (92% on average in January 2021, 82% in March 2022 - end of emergency in Italy - and 77% in June 2022). Reports are delivered on Thursdays to inform Regional Contacts. So far, weekly data inconsistencies ranged between 6% and 10%; they were all solved by variables cross-check, comparisons with previous information, and direct interviews with the LCTFs’ operators. Regularly, data are processed to monitor trends, with focus on waves of infections. In particular, prevalence of infections reached 1.4% and SARS-CoV-2 positive deaths 0.4% in January 2021 (vaccination campaign just started), 5.5% and 0.2% respectively in January 2022 (VC ≈ 97%), 4.0% and
- Published
- 2023
- Full Text
- View/download PDF
49. A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer
- Author
-
Chacon-Millan, Pilar, primary, Lama, Stefania, additional, Del Gaudio, Nunzio, additional, Gravina, Antonietta Gerarda, additional, Federico, Alessandro, additional, Pellegrino, Raffaele, additional, Luce, Amalia, additional, Altucci, Lucia, additional, Facchiano, Angelo, additional, Caraglia, Michele, additional, and Stiuso, Paola, additional
- Published
- 2024
- Full Text
- View/download PDF
50. #883 P-cresyl sulphate and Indoxyl sulphate: two uremic toxins stimulating colon cancer progression in patients with chronic renal failure
- Author
-
Simeoni, Mariadelina, primary, DI Paola, Rossella, additional, De, Ananya, additional, Izhar, Raafiah, additional, Abate, Marianna, additional, Zappavigna, Silvia, additional, Perna, Alessandra, additional, Capasso, Anna, additional, Capasso, Giovambattista, additional, and Caraglia, Michele, additional
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.